Xenotransplantation in Acute Liver Failure: Bridging the Organ Gap with Genetically Modified Porcine Livers
Highlight
- Xenotransplantation with genetically modified porcine livers offers a promising bridge therapy for patients with acute liver failure, addressing the critical organ shortage.
- Recent early clinical cases demonstrate technical feasibility and short-term viability of porcine liver grafts in extracorporeal support and auxiliary transplantation.
- Challenges remain, notably coagulopathy and immune-mediated injury, necessitating further genetic and immunologic refinements.
- Advances in gene editing, organ preservation, and machine perfusion technology underpin these translational breakthroughs.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
